- Trials with a EudraCT protocol (84)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (12)
84 result(s) found for: Duodenal.
Displaying page 1 of 5.
EudraCT Number: 2008-003696-43 | Sponsor Protocol Number: KUN 2008-4198 | Start Date*: 2008-11-25 |
Sponsor Name:KWF Kankerbestrijding | ||
Full Title: Prevention of progression of duodenal adenomas to cancer in patients with familial adenomatous polyposis | ||
Medical condition: Familial Adenomatous Polyposis Duodenal adenomas and carcinomas | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000594-81 | Sponsor Protocol Number: S65020 | Start Date*: 2021-05-07 |
Sponsor Name:University Hospitals Leuven (UZ Leuven) | ||
Full Title: The effect of corticotropin release hormone on duodenal markers and gastric sensorimotor function in healthy volunteers | ||
Medical condition: To assess the effect of the CRH on duodenal mast cell count, eosinophil count, immune activation, mucosal permeability and gastric sensorimotor function and gastrointestinal symptoms. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003631-37 | Sponsor Protocol Number: UDC1 | Start Date*: 2017-01-24 |
Sponsor Name:Universitaire ziekenhuis Leuven | ||
Full Title: Therapeutic effect of ursodeoxycholic acid on duodenal permeability and meal related sensory motor function in functional dyspepsia patients | ||
Medical condition: Functional dyspepsia (FD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005340-39 | Sponsor Protocol Number: S64807 | Start Date*: 2021-02-01 |
Sponsor Name:University Hospitals Leuven | ||
Full Title: Duodenal neuro-immune interactions and effects of proton pump inhibitors in functional dyspepsia | ||
Medical condition: Functional Dyspepsia (FD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004849-33 | Sponsor Protocol Number: Asp-Fam-01 | Start Date*: 2005-12-21 |
Sponsor Name:NHS Greater Glasgow | ||
Full Title: Prevention of oesophagitis, gastric and duodenal lesions in patients taking antithrombotic low-dose aspirin with famotidine | ||
Medical condition: Peptic ulceration induced by low-dose aspirin | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002593-27 | Sponsor Protocol Number: S64291 | Start Date*: 2022-06-17 |
Sponsor Name:UZ Leuven | ||
Full Title: Budesonide as a treatment for low-grade duodenal inflammation in functional dyspepsia. | ||
Medical condition: Functional dyspepsia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004248-39 | Sponsor Protocol Number: PPI-microbiome | Start Date*: 2018-01-04 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: Effect of Proton Pump Inhibitors on the duodenal microbiome in healthy volunteers | ||
Medical condition: We will assess the effect of Proton Pump Inhibitors (PPI) on the duodenal, oral and fecal microbiota composition in healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004355-23 | Sponsor Protocol Number: PPI-microbiome-FD | Start Date*: 2018-01-04 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: Effect of Proton Pump Inhibitors on the duodenal microbiome in Functional Dyspepsia patients | ||
Medical condition: Functional Dyspepsia (FD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003347-10 | Sponsor Protocol Number: PXR-HDL | Start Date*: 2017-01-16 |
Sponsor Name:Oulu University Hospital, Internal Medicine Research Unit | ||
Full Title: The effects of PXR activation on HDL-cholesterol | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-000427-41 | Sponsor Protocol Number: CPPFAP-310 | Start Date*: 2014-05-15 |
Sponsor Name:Cancer Prevention Pharmaceuticals, Inc. | ||
Full Title: A Double-Blind, Randomized, Phase III Trial of the Safety and Efficacy of CPP-1X/Sulindac Compared With CPP-1X, Sulindac as Single Agents in Patients with Familial Adenomatous Polyposis (FAP) | ||
Medical condition: Familial Adenomatous Polyposis (FAP) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) NL (Completed) ES (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000213-20 | Sponsor Protocol Number: D961WC00001 | Start Date*: 2023-06-06 | |||||||||||||||||||||
Sponsor Name:Astrazeneca K.K. | |||||||||||||||||||||||
Full Title: An Open Label, Parallel Group, Multi-centre, Phase III Study to Assess the Efficacy and Safety of D961H for the Maintenance Therapy Following Initial Treatment in Japanese Paediatric Patients with ... | |||||||||||||||||||||||
Medical condition: Reflux esophagitis in Japanese paediatric patients Past gastric ulcer or duodenal ulcer in Japanese paediatric patients | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003125-21 | Sponsor Protocol Number: P170915J | Start Date*: 2020-03-23 |
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | ||
Full Title: EFFECT OF INTRAVENOUS IRON SUPPLEMENTATION ON CELIAC DISEASE REMISSION IN PATIENTS WITH IRON DEFICIENCY AND INTESTINAL VILLOUS ATROPHY: A RANDOMIZED TRIAL | ||
Medical condition: Celiac patients with iron deficiency and intestinal villous atrophy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000612-54 | Sponsor Protocol Number: 0782-003 | Start Date*: 2004-09-11 |
Sponsor Name:Merck Sharp & Dohme (Sweden) AB | ||
Full Title: A Multicenter, Randomized, Parallel-Group, Active-Controlled Double-Blind Study Conducted Under In-House Blinding Conditions to Determine the Incidence of Gastroduodenal Ulcers in Patients With Ost... | ||
Medical condition: Osteoarthritis (OA) ICD: M19.9 MedDRA: 10031161 Rheumatoid Arthritis (RA) ICD: M06.9 MedDRA: 10039037 | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016082-29 | Sponsor Protocol Number: era-gastro-pancreas-001 | Start Date*: 2010-03-10 | |||||||||||
Sponsor Name:Erasme hospital | |||||||||||||
Full Title: Role of Lanreotide in the Management of Paraduodenal Pancreatitis | |||||||||||||
Medical condition: Paraduodenal pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018940-15 | Sponsor Protocol Number: FLDX-001 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:SALUS Haus GmbH & Co. KG | |||||||||||||
Full Title: A Phase IV, multi-centre, randomized, open label study to investigate the efficacy and safety of Floradix® mit Eisen and ferro sanol® duodenal mite 50 mg in pregnant women with diagnosed iron defic... | |||||||||||||
Medical condition: Pregnant women with diagnosed iron deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002209-12 | Sponsor Protocol Number: ABR59689 | Start Date*: 2017-06-21 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Erasmus MC-Sophia Children's Hospital | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Less opioids after major abdominal surgery in young infants using wound catheter infusion with local anesthetics: a randomized controlled trial. | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Children < 1 year of age undergoing major open abdominal surgery. | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000246-30 | Sponsor Protocol Number: FERINJECT | Start Date*: 2014-09-30 | ||||||||||||||||
Sponsor Name:IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest gGmbH | ||||||||||||||||||
Full Title: Intravenous ferric carboxymaltose vs. oral iron substitution in patients with metastatic colorectal cancer (CRC) and iron deficiency anemia: a randomized multicenter treatment optimization study. | ||||||||||||||||||
Medical condition: Iron deficiency anemia in patients with metastatic or inoperable colorectal cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-006258-99 | Sponsor Protocol Number: ECAMTEHP0012012 | Start Date*: 2012-04-02 | |||||||||||
Sponsor Name:Sección de Digestivo. Hospital Comarcal de Laredo | |||||||||||||
Full Title: FIRST-LINE ERADICATOR THERAPY OF HELICOBACTER PYLORI INFECTION: OPEN CLINICAL TRIAL, RANDOMIZED, MULTICENTRE, THREE-ARMED, COMPARING THE CLASSICAL TRIPLE THERAPY VERSUS A MODIFIED SEQUENTIAL THERAP... | |||||||||||||
Medical condition: Clinical situations where it is recommended the eradication of Helicobacter pylori: - Gastric or duodenal ulcer (active or not) and duodenal erosions - Gastric MALT lymphoma - First-degree relat... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006731-45 | Sponsor Protocol Number: PB-2006-01 | Start Date*: 2007-04-26 |
Sponsor Name:Køge Sygehus | ||
Full Title: PPI-Rebound-Trial | ||
Medical condition: This is a healthy volunteer trial designed to investigate if long-term treatment with nexium is the cause of a clinically significant acid rebound phenomenon. The intended indication for nexium is ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002241-30 | Sponsor Protocol Number: CEC-3/CEL | Start Date*: 2018-01-30 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: A phase IIa, double-blind, randomised, placebo-controlled, dose-finding study on the efficacy and tolerability of a 6-week treatment with ZED1227 capsules vs. placebo in subjects with well-controll... | |||||||||||||
Medical condition: Treatment of celiac disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) FI (Completed) DE (Completed) AT (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.